莱普托斯皮罗斯引起的凝血病和出血的发病原因
Lucas Jorge Da Silva Fernandes1,2, Mônica Larucci Vieira1,2
1Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Critical reviews in microbiology
|January 14, 2026
概括
莱普托斯皮罗斯症会破坏血液静止,导致出血障碍和血小板缺血. 本综述探讨了这些静血性障碍的分子基础,以指导未来的研究和干预.
科学领域:
- 病理学 病理学 病理学
- 传染性疾病 传染性疾病
- 血液学 血液学 血液学
背景情况:
- 生理血液静止涉及促凝和抗凝途径的复杂平衡.
- 血静与炎症和免疫反应密切相关.
- 由于Leptospira* 细菌引起的白血病严重破坏了这种平衡,导致凝血病和出血.
研究的目的:
- 审查和分析勒托斯皮罗斯症中静血功能障碍的病理生理学.
- 阐明内脏病变,促凝血/促炎症状态和血小板功能障碍的作用.
- 为了指导未来的研究,在分子机制的白螺旋病相关的凝血病.
主要方法:
- 文献综述和现有关于白螺旋病和血液静止的研究的分析.
- 关于血液静止障碍分子病原学的信息综合.
- 专注于内脏病变,凝血,炎症和血小板功能.
主要成果:
- 莱普托斯皮罗斯引起血液静止平衡的显著干扰.
- 血小板缺血是与不良结果相关的常见并发症.
- 内脏病变,促凝血/促炎症状态和血小板功能障碍是主要的贡献者.
结论:
- 了解白螺杆菌病的凝血病的分子病原体是至关重要的.
- 这种知识可以为开发新型治疗干预措施提供信息.
- 需要进一步的研究才能完全解开所涉及的复杂机制.
相关概念视频
Bacterial Phylum Spirochaetes
587
Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased...
587
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
Introduction to Hemostasis
13.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.3K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K


